Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Letestu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annales De Biologie Clinique|January 9, 2004
[Bone marrow aspiration for diagnostic purposes]R Letestu, F Valensi
Thrombosis and Haemostasis|May 24, 2000
Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiationN Vitrat, R Letestu, A Massé, et al.
British Journal of Haematology|December 22, 1999
Intracellular trafficking of the alphaIIbbeta3 receptor antagonist, abciximab, in normal and Glanzmann's disease megakaryocytesJ M Massé, K Perlemuter, N Debili, et al.
Dakar Medical|November 22, 2005
[Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]S Diop, R Letestu, D Orsolani, et al.
Blood|February 25, 1999
Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesisC Rivière, F Subra, K Cohen-Solal, et al.
Blood|March 27, 2001
Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonatesN Debili, C Robin, V Schiavon, et al.
Leukemia|March 19, 2004
Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disordersR Letestu, V Ugo, F Valensi, et al.
Blood|February 26, 2000
Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndromeR Letestu, N Vitrat, A Massé, et al.
International Journal of Laboratory Hematology|July 31, 2010
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100™G Le Roux, A Vlad, V Eclache, et al.
Leukemia Research|July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine AC Kelaidi, T Braun, R Arana, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annales De Biologie Clinique|January 9, 2004
[Bone marrow aspiration for diagnostic purposes]R Letestu, F Valensi
Thrombosis and Haemostasis|May 24, 2000
Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiationN Vitrat, R Letestu, A Massé, et al.
British Journal of Haematology|December 22, 1999
Intracellular trafficking of the alphaIIbbeta3 receptor antagonist, abciximab, in normal and Glanzmann's disease megakaryocytesJ M Massé, K Perlemuter, N Debili, et al.
Dakar Medical|November 22, 2005
[Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]S Diop, R Letestu, D Orsolani, et al.
Blood|February 25, 1999
Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesisC Rivière, F Subra, K Cohen-Solal, et al.
Blood|March 27, 2001
Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonatesN Debili, C Robin, V Schiavon, et al.
Leukemia|March 19, 2004
Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disordersR Letestu, V Ugo, F Valensi, et al.
Blood|February 26, 2000
Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndromeR Letestu, N Vitrat, A Massé, et al.
International Journal of Laboratory Hematology|July 31, 2010
Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100™G Le Roux, A Vlad, V Eclache, et al.
Leukemia Research|July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine AC Kelaidi, T Braun, R Arana, et al.
Pageof 2